• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Model Number 10220
Device Problem Insufficient Information (3190)
Patient Problems Diarrhea (1811); Erythema (1840); Fever (1858); Rash (2033); Tachycardia (2095)
Event Date 08/25/2022
Event Type  Injury  
Manufacturer Narrative
Lot number and expiry information are not available at this time.Investigation is in process.A follow-up report will be provided.Citation: phou s, perez-alvarez i, morgan m, contreras da, ben-aderet m, gaddam e, et al.Successful autologous hematopoietic stem cell transplants using salmonella positive products collected from asymptomatic donors.Transfusion.2023;63(4): 861¿6.Https://doi.Org/10.1111/trf.17306.
 
Event Description
Per the journal article, "successful autologous hematopoietic stem cell transplants using salmonella positive products collected from asymptomatic donors." by phou, s.,perez-alvarez, et.Al."the patient tolerated the infusion well.On day 4 post-hsc infusion, she was started on levofloxacin as part of standard infectious disease prophylaxis which was switched to cefepime on day 6 given tachycardia to 110 bpm.On day 8, she began having ongoing fevers (peakat104°f)and cefepime was switched to meropenem.On day 10, she experienced diarrhea.On days 11, 12, she developed facial erythema, leg swelling, apetechial rash on the upper extremities, and a tachycardic episode to 170 bpm.Blood cultures collected on days 6, 8, and 12 were all negative.Given concern for engraftment syndrome, she was given solumedrol on days 12¿14 with transition to aprednisone taper.She improved clinically and was discharged on day 15.Neutrophil engraftment occurred on day 12 and platelet engraftment by day 25.On follow up day 85, she was doing well clinically." the collection set is not available for return because it was discarded by the customer.Specific details were not included in the article for these events; therefore this report is being provided as a summary of the events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key16935966
MDR Text Key315271893
Report Number1722028-2023-00181
Device Sequence Number1
Product Code LKN
UDI-Device Identifier05020583102200
UDI-Public05020583102200
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K183081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/15/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number10220
Device Catalogue Number10220
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/20/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age45 YR
Patient SexFemale
-
-